Valsartan

Valsartan

Products
Valsartan
Valsartan

Information

Dr. Reddy's has the capabilities and capacities to manufacture and deliver sartan APIs in accordance with global regulations. Our team of experts developed processes and the analytical methods to avoid the presence of nitrosamine impurities, which are already suitable to confirm future requirements of the EMA (NDEA or NDMA limits of <0.03 ppm).
Main Categories
APIs (Active Pharmaceutical Ingredients)
All Categories
APIs (Active Pharmaceutical Ingredients)
Distribution areas
North America (USA, Canada)East Asia (e.g. China, Japan, Korea)Europe - EU countriesEurope - non EU (e.g. UK, Russia, ex-CIS countries)South Asia (e.g. India, Pakistan, Sri Lanka)South East Asia (e.g. Thailand, Philippines, Singapore)
Supplied from
India
Dr. Reddy's Laboratories SA.We are a global pharmaceutical company headquartered in Hyderabad, India. Established in 1984, we are committed to providing access to affordable and innovative medicines because we believe 'Good Health Can't Wait'. We offer a portfolio of products and services, including APIs, generics, branded generics, biosimilars and OTC. Our therapeutic focus areas are gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. Our primary markets include - the US, India, Russia & CIS countries, China, Brazil, and Europe. As a company with a history of deep science that has led to several industry firsts, we continue to invest in businesses of the future. As an early adopter of sustainability and ESG frameworks, we released our first Sustainability Report in 2004. Our current ESG goals aim to set the bar high for the environment but also to drive access to healthcare for more than 1.5 bn by 2030.

Log in

See all the content and easy-to-use features by logging in or registering!